NET Assay(s)

Background Information

The norepinephrine transporter (NET), encoded by the SLC6A2 gene, is a sodium- and chloride-dependent symporter responsible for the reuptake of norepinephrine from the synaptic cleft into presynaptic neurons. By tightly controlling extracellular norepinephrine levels, NET plays a key role in modulating noradrenergic signaling in both the central and peripheral nervous systems, particularly in brain regions such as the locus coeruleus, hippocampus, and prefrontal cortex. Dysregulation of NET function has been implicated in various neuropsychiatric and cardiovascular disorders, including depression, anxiety, attention-deficit/hyperactivity disorder (ADHD), orthostatic intolerance, and postural tachycardia syndrome.

Family: SLC Transporter
Protein Name: NET
Gene Name: SLC6A2

Organism : Human
Therapeutic Area: CNS, Cardiovascular

Assay Information

Validated Assay(s): Neurotransmitter Uptake Assay
Assay type: Cell-based
Method: Fluorescence

Instrumentation: FLIPR, Panoptic, Flexstation
Plate Format: 96- or 384-well
Expression: Stable
Cell type: HEK293T

Testing Information

Functional Mode(s): Inhibitor
Reference compound(s): Norepinephrine

Dose response curve for a DAT inhibition assay using a Neurotransmitter Uptake assay and the inhibitor, Nisoxetine.

Enquire now